ilmscore | Prediction Details
"four of which are in phase two and expecting results within the next two quarters"
By Let's Talk Money! with Joseph Hogue, CFA | January 3, 2025 | Pending
From video
7 Stocks to Buy Now for 100% Returns in 2025 00:11:42 - 00:11:45
Interpreted Prediction
Recursion Pharmaceuticals (RXRX) is expecting results from four Phase Two clinical trials within Q1-Q2 2025.

Prediction Details

Ticker
RXRX
Initial Price
7.8 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.